Target intelligence / Profile preview

THUMP domain-containing protein 2 (THUMPD2)

Target
THUMPD2
Molecular classification
Enzyme, Methyltransferase, RNA-binding protein
01

Overview

THUMP domain-containing protein 2 (THUMPD2) is an RNA methyltransferase that forms a complex with TRMT112 to specifically catalyze the S-adenosylmethionine (SAM)–dependent N(2)-methylation of guanosine at position 72 (m²G72) in U6 small nuclear RNA (snRNA), a core component of the major spliceosome[1][2][3]. This post-transcriptional RNA modification is essential for efficient pre-mRNA splicing, particularly affecting introns with suboptimal splice sites, and impacts global mRNA processing in human cells[1][2][3]. Loss of THUMPD2-mediated U6 m²G72 methylation impairs splicing activity and can lead to widespread alternative splicing events, induction of nonsense-mediated decay, and is associated with retinal pathologies including age-related macular degeneration[1][2]. THUMPD2 is ubiquitously expressed in multiple cell types and tissues and operates mainly in the nucleus, consistent with its role in spliceosome function[1].

Other names
THUMP domain-containing protein 2C2orf8U6 snRNA (guanine-N(2))-methyltransferase THUMPD2SAM-dependent methyltransferaseMGC2454
02

Biological functions

Methylation (N(2)-methylation of guanosine in U6 snRNA)Regulation of pre-mRNA splicing via the spliceosomeRNA bindingRegulation of alternative mRNA splicing
03

Disease associations

Retinal degenerationAge-related macular degenerationGingival fibromatosis

Beyond the preview

Go deeper on THUMP domain-containing protein 2 (THUMPD2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on THUMP domain-containing protein 2 (THUMPD2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call